Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Non-Small-Cell Lung × Tadalafil × 1 year × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 2 Carcinoma 2 Squamous Cell Carcinoma of Head and Neck 1 Pyridoxine-dependent epilepsy 1 Peripheral Nervous System Diseases 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neurotoxicity Syndromes 1 Neoplasms 1 Neoplasm Metastasis 1 Mouth Neoplasms 1 Liver Neoplasms 1 Head and Neck Neoplasms 1 Gastric Adenocarcinoma 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Hepatocellular 1 Adenocarcinoma 1

Interventions

pembrolizumab 248 Carboplatin 207 Pemetrexed 180 Cisplatin 128 Paclitaxel 113 Nivolumab 96 osimertinib 84 Docetaxel 81 durvalumab 79 Specimen Handling 56 atezolizumab 55 Drug Therapy 53 Magnetic Resonance Spectroscopy 49 Gemcitabine 49 Radiotherapy 47 Radiosurgery 43 Ipilimumab 40 cemiplimab 38 Bevacizumab 37 130-nm albumin-bound paclitaxel 35 tislelizumab 32 Cetuximab 27 amivantamab 22 Immune Checkpoint Inhibitors 22 Blood Specimen Collection 20 Taxes 19 Platinum Compounds 19 Immunotherapy 19 Surgical Procedures, Operative 17 Erlotinib Hydrochloride 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡